Clopidogrel Bi recalls

The FDA has published 2 recalls involving Clopidogrel Bi since 2018. The latest was reported on 19 Dec 2018. Most were for potency & assay. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 19 Dec 2018

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why clopidogrel bi is recalled

Potency & Assay2100%

Companies

Dr. Reddy's Laboratories2100%

By year

20182100%

All clopidogrel bi recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
19 Dec 2018Drug	CLASS II	Clopidogrel Tablets, USP, 300 mg, 30 ( unit-dose) count recalledClopidogrel Bisulfate	Dr. Reddy's Laboratories	Potency & Assay	Nationwide
28 Nov 2018Drug	CLASS II	Clopidogrel Tablets, USP, 300 mg, 30 ( unit-dose) count recalledClopidogrel Bisulfate	Dr. Reddy's Laboratories	Potency & Assay	Nationwide

Should you stop taking Clopidogrel Bi?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.